Dorzolamide is a pharmaceutical raw material used as a carbonic anhydrase inhibitor. It is indicated for reducing elevated intraocular pressure in conditions such as glaucoma, with onset of action within three hours and a duration of at least eight hours when administered as an eye drop.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 120279-96-1
Dorzolamide hydrochloride
pharmaceutical raw material
Dorzolamide N-Sulfonamide Dimer
Research compound
Cetrorelix
pharmaceutical raw material
Biapenem
pharmaceutical raw material
Icotinib hydrochloride
pharmaceutical raw material
Samidorphan L-malate
pharmaceutical raw material
(+/-)-(cis)-dorzolamide hydrochloride
pharmaceutical raw material
N-[(4S,6S)-6-Methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide
pharmaceutical intermediate
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide
IAVUPMFITXYVAF-XPUUQOCRSA-N
CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C